Regulation of proteolysis by deubiquiting enzyme in lung inflammatory disease
肺部炎症疾病中去泛素化酶对蛋白水解的调节
基本信息
- 批准号:9912813
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-11-10 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcute Lung InjuryAftercareAnti-Inflammatory AgentsAntsAttenuatedBackBacterial InfectionsBindingBiologicalBleomycinBlood capillariesCD14 geneCell surfaceCellsComplexDataDeubiquitinating EnzymeDevelopmentDiseaseEdemaEndotheliumEndotoxinsEnzymesEpithelialEpitheliumEtiologyExtravasationFocal InfectionG-Protein-Coupled ReceptorsGTP-Binding ProteinsInfectionInflammatoryInflammatory ResponseInjuryInterruptionIonsLTB4R geneLifeLinkLipopolysaccharidesLungLung InflammationLung diseasesLysophosphatidic Acid ReceptorsLysosomesMediatingModelingMole the mammalMolecularMorbidity - disease rateOrgan failurePathogenesisPathway interactionsPeptidesPharmacologyPhosphorylationPlayPneumoniaProteinsPseudomonas aeruginosaRecyclingRegulationRegulation of ProteolysisResearchRoleSchemeSepsisSeveritiesShockSignal TransductionSystemTestingTissuesUbiquitinUbiquitinationUp-RegulationVirulentbaseclinical carecytokinecytokine release syndromeendotoxin receptorimprovedinflammatory lung diseaseknock-downlung injurymortalityneutrophilnovelnovel therapeutic interventionnovel therapeuticspathogenreceptorresponsesmall moleculeubiquitin isopeptidaseubiquitin-specific protease
项目摘要
Abstract
An uncontrolled cytokine storm in lungs leads to detrimental effects such as neutrophil influx, capillary
leakage, tissue edema, and organ failure often manifested as pneumonia-induced acute lung injury (ALI).
Lysophosphatidic acid receptor 1 (LPA1) is a pro-inflammatory G protein coupled receptor, which induces pro-
inflammatory cytokine release through Gα-mediated signaling and interaction with endotoxin receptor, CD14.
LPA1 has been implicated in the pathogenesis of lung inflammatory disorders. Knockdown or inhibition of
LPA1 attenuates endotoxin- or bleomycin-induced lung injury and sepsis. We discovered that LPA1 stability is
regulated in the ubiquitin-lysosome system. Ubiquitin-specific protease 11 (USP11) deubiquitinates and
stabilizes LPA1, thus promoting LPA1-modulated pro-inflammatory effects. Knockdown of USP11 reduces
LPA1 stability and attenuates both LPA- and LPS-induced lung inflammation. This is the first to demonstrate
that destabilizing LPA1 reduces lung inflammation, and deubiquitinating enzyme contributes to the
pathogenesis of lung injury. We have developed a small blocking peptide (LDPep) to interrupt the interaction
between LPA1 and USP11, which specifically reduces LPA1 protein level, without altering expression of other
LPA receptors and USP11 target proteins. LDPep post-treatment lessens endotoxin-induced lung injury and
sepsis shock. This project will explore a novel therapeutic approach for treating inflammatory disorders like
ALI and sepsis. Execution of these studies will lay the groundwork for a significant mechanistic advance in the
molecular regulation of pro-inflammatory responses during severe infection. Results from these studies can
serve as the basis for further development of pharmacologic agents that destabilize LPA1, thereby reducing
severity of inflammatory diseases such as lung injury and sepsis.
摘要
肺中不受控制的细胞因子风暴导致有害作用,如中性粒细胞流入、毛细血管炎、炎症和炎症。
渗漏、组织水肿和器官衰竭常表现为肺炎引起的急性肺损伤(ALI)。
溶血磷脂酸受体1(LPA 1)是促炎性G蛋白偶联受体,其诱导促炎性细胞因子的产生。
通过Gα介导的信号传导和与内毒素受体CD 14相互作用释放炎性细胞因子。
LPA 1与肺部炎症性疾病的发病机制有关。击倒或抑制
LPA 1减弱内毒素或博来霉素诱导的肺损伤和脓毒症。我们发现LPA 1的稳定性
在泛素-溶酶体系统中调节。泛素特异性蛋白酶11(USP 11)去泛素化,
稳定LPA 1,从而促进LPA 1调节的促炎作用。USP 11的敲除降低了
LPA 1稳定性和减弱LPA和LPS诱导的肺部炎症。这是第一个证明
LPA 1的不稳定性降低了肺部炎症,而去泛素化酶有助于
肺损伤的发病机制。我们已经开发了一种小阻断肽(LDPep)来中断相互作用
在LPA 1和USP 11之间,它特异性地降低LPA 1蛋白水平,而不改变其他蛋白的表达。
LPA受体和USP 11靶蛋白。LDPep后处理减轻内毒素诱导的肺损伤,
败血症休克该项目将探索一种新的治疗方法,用于治疗炎症性疾病,
急性肺损伤和败血症。这些研究的执行将为在生物医学领域取得重大的机械进展奠定基础。
严重感染期间促炎反应的分子调节。这些研究的结果可以
作为进一步开发使LPA 1不稳定的药理学试剂的基础,
炎性疾病如肺损伤和脓毒症的严重程度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yutong Zhao其他文献
Yutong Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yutong Zhao', 18)}}的其他基金
Molecular regulation of BMPRII stability in lung fibrosis
肺纤维化中 BMPRII 稳定性的分子调节
- 批准号:
10712273 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10180376 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10394303 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10614448 - 财政年份:2021
- 资助金额:
$ 39万 - 项目类别:
Molecular regulation of anti-inflammatory cytokine receptor in sepsis
脓毒症抗炎细胞因子受体的分子调控
- 批准号:
9912821 - 财政年份:2018
- 资助金额:
$ 39万 - 项目类别:
Regulation of proteolysis by deubiquiting enzyme in lung inflammatory disease
肺部炎症疾病中去泛素化酶对蛋白水解的调节
- 批准号:
9237362 - 财政年份:2017
- 资助金额:
$ 39万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8851660 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8666032 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
9067468 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8499556 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别: